Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Pegdinetanib> ?p ?o }
Showing triples 1 to 66 of
66
with 100 triples per page.
- Pegdinetanib abstract "Pegdinetanib (USAN; planned trade name Angiocept) is an investigational anti-cancer drug that acts as a selective antagonist of vascular endothelial growth factor receptor 2 (VEGFR-2), hindering vascularization of tumors. It is a genetically engineered peptide derivative based on the monobody technology, and is being developed by Adnexus.The drug has entered Phase II clinical trials investigating the treatment of glioblastoma in October 2007. As of August 2012, it is also in Phase II trials for the treatment of non-small cell lung cancer and colorectal cancer.".
- Pegdinetanib atcPrefix "None".
- Pegdinetanib casNumber "906450-24-6".
- Pegdinetanib thumbnail Pegdinetanib_non-peptide_structure.svg?width=300.
- Pegdinetanib wikiPageID "36807328".
- Pegdinetanib wikiPageLength "5670".
- Pegdinetanib wikiPageOutDegree "21".
- Pegdinetanib wikiPageRevisionID "695668101".
- Pegdinetanib wikiPageWikiLink Adnexus.
- Pegdinetanib wikiPageWikiLink Angiogenesis_inhibitor.
- Pegdinetanib wikiPageWikiLink Atomic_mass_unit.
- Pegdinetanib wikiPageWikiLink Category:Antibody_mimetics.
- Pegdinetanib wikiPageWikiLink Category:Antineoplastic_drugs.
- Pegdinetanib wikiPageWikiLink Chemotherapy.
- Pegdinetanib wikiPageWikiLink Clinical_trial.
- Pegdinetanib wikiPageWikiLink Colorectal_cancer.
- Pegdinetanib wikiPageWikiLink Cysteine.
- Pegdinetanib wikiPageWikiLink Genetic_engineering.
- Pegdinetanib wikiPageWikiLink Glioblastoma_multiforme.
- Pegdinetanib wikiPageWikiLink Intravenous_therapy.
- Pegdinetanib wikiPageWikiLink Kinase_insert_domain_receptor.
- Pegdinetanib wikiPageWikiLink Maleimide.
- Pegdinetanib wikiPageWikiLink Monobody.
- Pegdinetanib wikiPageWikiLink Non-small-cell_lung_carcinoma.
- Pegdinetanib wikiPageWikiLink PEGylation.
- Pegdinetanib wikiPageWikiLink Peptide.
- Pegdinetanib wikiPageWikiLink Receptor_antagonist.
- Pegdinetanib wikiPageWikiLink United_States_Adopted_Name.
- Pegdinetanib wikiPageWikiLinkText "Pegdinetanib".
- Pegdinetanib wikiPageWikiLinkText "pegdinetanib".
- Pegdinetanib atcPrefix "None".
- Pegdinetanib c "468".
- Pegdinetanib casNumber "906450".
- Pegdinetanib chemspiderid "none".
- Pegdinetanib h "729".
- Pegdinetanib legalStatus "Investigational".
- Pegdinetanib n "125".
- Pegdinetanib o "139".
- Pegdinetanib routesOfAdministration Intravenous_therapy.
- Pegdinetanib s "1".
- Pegdinetanib synonyms "CT-322; BMS-844203".
- Pegdinetanib tradename "Angiocept".
- Pegdinetanib width "250".
- Pegdinetanib wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- Pegdinetanib wikiPageUsesTemplate Template:As_of.
- Pegdinetanib wikiPageUsesTemplate Template:Drugbox.
- Pegdinetanib wikiPageUsesTemplate Template:Reflist.
- Pegdinetanib subject Category:Antibody_mimetics.
- Pegdinetanib subject Category:Antineoplastic_drugs.
- Pegdinetanib hypernym Drug.
- Pegdinetanib type ChemicalSubstance.
- Pegdinetanib type Drug.
- Pegdinetanib type Chemical.
- Pegdinetanib type Drug.
- Pegdinetanib type Redirect.
- Pegdinetanib type ChemicalObject.
- Pegdinetanib type Thing.
- Pegdinetanib type Q8386.
- Pegdinetanib comment "Pegdinetanib (USAN; planned trade name Angiocept) is an investigational anti-cancer drug that acts as a selective antagonist of vascular endothelial growth factor receptor 2 (VEGFR-2), hindering vascularization of tumors. It is a genetically engineered peptide derivative based on the monobody technology, and is being developed by Adnexus.The drug has entered Phase II clinical trials investigating the treatment of glioblastoma in October 2007.".
- Pegdinetanib label "Pegdinetanib".
- Pegdinetanib sameAs Q7160603.
- Pegdinetanib sameAs m.0ll2ryf.
- Pegdinetanib sameAs Q7160603.
- Pegdinetanib wasDerivedFrom Pegdinetanib?oldid=695668101.
- Pegdinetanib depiction Pegdinetanib_non-peptide_structure.svg.
- Pegdinetanib isPrimaryTopicOf Pegdinetanib.